IRD COUNTS Invites You To Participate In A Survey

18 March 2019
Source: IRD counts

Inherited Retinal Dystrophies Consortium Operating for the Under-Represented for Novel Therapies and Services IRD COUNTS AND SO DO YOU! HAVE YOUR SAY! YOUR EXPERIENCE IS IMPORTANT! IRD COUNTS Invites You To Participate In A Survey Of Inherited Retinal Disease (IRD) Patients And Those Who Care For Them Have you or someone you know been diagnosed with an IRD? The impact

Read more IRD COUNTS Invites You To Participate In A Survey
IRD Survey Flyer
IRD Survey Flyer
Download pptx 0.6 MB

Fight for Sight: Research to improve survival rates for patients with eye cancer

15 March 2019
Source: Fight for Sight

Fight for Sight is this week announcing research to identify new treatments that could improve survival rates for an eye cancer called uveal melanoma. Researchers from the University of Liverpool will be analysing tumour samples to gain a better understanding about the role of mutation in a gene known as BAP1 in the development of uveal melanoma. The underlying changes

Read more Fight for Sight: Research to improve survival rates for patients with eye cancer

BBC News: Gene therapy first to ‘halt’ AMD the most common cause of blindness

19 February 2019
Source: BBC News

A woman from Oxford has become the first person in the world to have gene therapy to try to halt the most common form of blindness in the Western world. Surgeons injected a synthetic gene into the back of Janet Osborne’s eye in a bid to prevent more cells from dying. It is the first treatment to target the underlying

Read more BBC News: Gene therapy first to ‘halt’ AMD the most common cause of blindness

Macular degeneration trial will be first human test of Nobel-winning stem cell technique

18 January 2019
Source: STAT

Curing diabetes with stem cells? Everyone knew that would be hard. Parkinson’s disease? Harder. Alzheimer’s? Probably impossible. But age-related macular degeneration, a major cause of blindness? That was supposed to be low-hanging fruit. The cause of AMD is well-known, the recipe for turning stem cells into retinal cells works like a charm, and the eye is “immunoprivileged,” meaning immune cells

Read more Macular degeneration trial will be first human test of Nobel-winning stem cell technique

BBC News: Brexit: Universities warn no deal is ‘biggest-ever threat’

4 January 2019
Source: BBC News

University heads are warning a no-deal Brexit is “one of the biggest threats” the institutions have ever faced. Higher education leaders have written to MPs to say it is “no exaggeration” to warn that it would take universities “decades to recover”. They say it would undermine scientific research and threaten universities’ £21bn contribution to the UK economy. See the full

Read more BBC News: Brexit: Universities warn no deal is ‘biggest-ever threat’

Therapeutic Advances in Ophthalmology: Corneal endothelial cell dysfunction: etiologies and management

7 December 2018
Source: Therapeutic Advances in Ophthalmology

Abstract   A transparent cornea is essential for the formation of a clear image on the retina. The human cornea is arranged into well-organized layers, and each layer plays a significant role in maintaining the transparency and viability of the tissue. The endothelium has both barrier and pump functions, which are important for the maintenance of corneal clarity. Many etiologies,

Read more Therapeutic Advances in Ophthalmology: Corneal endothelial cell dysfunction: etiologies and management

Retina UK: Gene therapy for RPE65 gene approved for use in EU

23 November 2018
Source: Retina UK

The gene therapy Luxturna has won European regulatory approval for the treatment of Inherited retinal dystrophy caused by mutations in the RPE65 gene. This milestone decision was made by the European Medicines Agency (EMA) on Thursday, 22 November. Luxturna is the first and only gene therapy available in Europe to treat inherited retinal disease. It had already been approved for

Read more Retina UK: Gene therapy for RPE65 gene approved for use in EU

NIHR: Eye disease patients have more opportunity than ever to take part in NHS research studies

21 November 2018
Source: NIHR

• 76 per cent of hospitals in England now offer patients the opportunity to take part in eye disease studies • 15,500 patients per year offered innovative treatments for diseases such as age-related macular degeneration • Ophthalmology community ‘punching above its weight’ in world of research A new paper published today highlights how some 76 per cent of hospitals in

Read more NIHR: Eye disease patients have more opportunity than ever to take part in NHS research studies

Macular Society: Diabetes medication may protect against AMD

14 November 2018
Source: Macular Society

Researchers from Taiwan have shown that people with type 2 diabetes who took a common diabetes medication, had a significantly lower rate of age-related macular degeneration (AMD). The study suggests that the anti-inflammatory and anti-oxidative effects of the drug metformin can protect against AMD, while it controls diabetes. The research was presented at AAO 2018, the 122nd Annual Meeting of

Read more Macular Society: Diabetes medication may protect against AMD